Glaxosmithkline Pharmaceuticals Ltd - Stock Price

As on12 Aug 2020
  • NSE : GLAXO
  • BSE : 500660
  • ISIN CODE : INE159A01016
  • Industry : Pharmaceuticals & Drugs
  • House : Glaxosmithkline - MNC
Glaxosmithkline Pharmaceuticals Ltd is not traded on BSE/NSE
1456.50
-1.13 %-16.7
Previous Close 1473.20
Day's Open 1481.90
Bid Price (Qty) 1456.50 (104)
Offer Price (Qty) 0.00 (0)
Day’s High - Low 1481.90 - 1455.55
52 Week Range 962.65 - 1748
Volume Traded (in 000's) 58.76
Value traded (in Cr.) 8.62
PE Ratio (x) 229.63
M Cap (in Cr.)24696.86

Glaxosmithkline Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 24696.86
Earning Per Share (EPS TTM) (Rs.) 6.35
Price To Earnings (P/E) Ratio 229.63
Book Value Per Share (Rs.) 115.17
Price/Book (MRQ) 12.66
Price/Earning (TTM) 128.00
ROCE (%) 16.51
PAT Margin 3.41
Dividend Yield 2.74
Face Value 10

Financial Summary

Parameter MAR 20 (`Mn.) MAR 19 (`Mn.) YoY %Change
Balance Sheet :
Share Capital1694.061694.060.00
Total Non-Current Liabilities30425.4328603.696.37
Total Current Liabilities23693.0928040.66-15.50
Total Liabilities72324.5778042.64-7.33
Total Non-Current Assets41125.2344450.55-7.48
Currents Investments0.000.000.00
Cash and Bank10832.0311713.46-7.52
Total Current Assets31199.3333592.09-7.12
Total Assets72324.5778042.64-7.33
Profit & Loss :
Gross Sales32243.8031281.203.08
Net Sales32243.8031281.203.08
Total Expenditure25671.3025273.201.58
Operating Profit7362.607031.204.71
Profit After Tax932.004453.90-79.07
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
Quant Mid Cap Fund(G)9.42
Quant Large & Mid Cap Fund(G)7.25
Aditya Birla SL MNC Fund-Reg(G)7.11
Quant Consumption Fund(G)5.87
Aditya Birla SL Tax Plan(D)5.36
Aditya Birla SL Tax Relief '96(D)5.33
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Peer Comparison

More Comparison »

Share Holdings

Description Percent of Share (%)
Promoters75
Non-Institution12.66
Fi/Banks/Insurance6.78
Mutual Funds/Uti4.81
FII0
Government0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: R S Karnad
  • Managing Director: S Venkatesh
  • Secretary: Ajay Nadkarni

Registered Office

Address : Dr Annie Besant Road,Worli, Mumbai,
Maharashtra-400030 Tel : 022-24959595 Fax : 022-24959494 Email : askus@gsk.com Website : www.gsk-india.com

Registars Details

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1474.4. Its current market capitalisation stands at Rs 24696.86 Cr. In the latest quarter, company has reported Gross Sales of Rs. 32243.81 Cr and Total Income of Rs.33033.93 Cr. The company's management includes S Maheshwari, S Williams, P Thakur, D Sundaram, A N Roy, R Krishnaswamy, N Kaviratne ( C B E ), PV Bhide, S Venkatesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

Latest News

close